J-Pharma Co (TSE:520A) Research & Development: 円 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:520A J-Pharma Co Ltd TSE:520A
9 GF Score
Price 円290.00
View Full Analysis

What is J-Pharma Co Research & Development?

J-Pharma Co TSE:520A -2.36% 9 Research & Development is 円 Mil as of Dec. 2025. GuruFocus rates TSE:520A with a GF Score™ of 9/100.

Research & Development is the aggregate amount of research and development expenses during the year. J-Pharma Co's Research & Development for the three months ended in Dec. 2025 was 円466.46 Mil. J-Pharma Co does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in Dec. 2025.

J-Pharma Co  (TSE:520A) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

J-Pharma Co Research & Development Related Terms

J-Pharma Co Research & Development Historical Data

* Premium members only.

The historical data trend for J-Pharma Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

J-Pharma Co Research & Development Chart

J-Pharma Co Annual Data
Trend Mar24 Mar25
Research & Development
1,116.26 1,217.00

J-Pharma Co Quarterly Data
Mar24 Mar25 Dec25
Research & Development 0.00 0.00 466.46
TSE:520A
9GF Score
J-Pharma Co Ltd TSE:520A
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

J-Pharma Co Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円 Mil mean?
J-Pharma Co (TSE:520A) has a Research & Development of 円 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on J-Pharma Co and its competitors.
Is J-Pharma Co's Research & Development too high?
J-Pharma Co's current Research & Development is 円 Mil. Overall, J-Pharma Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does J-Pharma Co's Research & Development compare to VRTX and REGN?
J-Pharma Co's Research & Development of 円 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on J-Pharma Co and its competitors. J-Pharma Co's current Research & Development is 円 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J-Pharma Co stock overvalued right now?
J-Pharma Co (TSE:520A) has a current Research & Development of 円 Mil. The current Research & Development is 円 Mil. J-Pharma Co's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For J-Pharma Co (TSE:520A), the current Research & Development is 円 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

J-Pharma Co Business Description

Address 1-10-11, HamamatsuCho, 8th floor, Minato-Ku, Tokyo, JPN, 105-0013
J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. It is focused on a single segment of the drug discovery business, focusing on R&D and clinical development. The company's two compounds in clinical development are Nanbran Latte (JPH203) and JPH034.
9GF Score

Get the complete analysis for TSE:520A

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円290.00
Price